Increased Permeability of the Blood–Brain Barrier in a Diabetic Mouse Model (Leprdb/db Mice)
Authors:
- Musaad A. AlshammariMAMusaad A. Alshammari
- Abdulaziz O. AlshehriAAAbdulaziz O. Alshehri
- Faleh AlqahtaniFAFaleh Alqahtani
- Mohammad R. KhanMKMohammad R. Khan
- Muhammed A. BakhrebahMBMuhammed A. Bakhrebah
- Fawaz AlasmariFawaz Alasmari
- Tahani K. AlshammariTATahani K. Alshammari
- Shakir D. AlsharariSAShakir D. Alsharari
Open Access
- 16 July 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (14) , 7768
Abstract
Type 2 Diabetes Mellitus (T2DM) is linked to multiple complications, including cognitive impairment, and the prevalence of memory-related neurodegenerative diseases is higher in T2DM patients. One possible theory is the alteration of the microvascular and macrovascular environment of the blood–brain barrier (BBB). In this study, we employed different approaches, including RT-PCR, functional pharmacokinetic studies using sodium fluorescein (NaFL), and confocal microscopy, to characterize the functional and molecular integrity of the BBB in a T2DM animal model, leptin receptor-deficient mutant mice (Leprdb/db mice). As a result, VCAM-1, ICAM-1, MMP-9, and S100b (BBB-related markers) dysregulation was observed in the Leprdb/db animal model compared to littermate wild-type mice. The brain concentration of sodium fluorescein (NaFL) increased significantly in Leprdb/db untreated mice compared to insulin-treated mice. Therefore, the permeability of NaFL was higher in Leprdb/db control mice than in all remaining groups. Identifying the factors that increase the BBB in Leprdb/db mice will provide a better understanding of the BBB microvasculature and present previously undescribed findings of T2DM-related brain illnesses, filling knowledge gaps in this emerging field of research.Keywords
Funding Information
- King Abdulaziz City for Science and Technology (3-17-05-001-0051)
This publication has 80 references indexed in Scilit:
- Quantitative Phenotyping of Cell–Cell Junctions to Evaluate ZO-1 Presentation in Brain Endothelial CellsAnnals of Biomedical Engineering, 2019
- Hyperglycemia-Driven Neuroinflammation Compromises BBB Leading to Memory Loss in Both Diabetes Mellitus (DM) Type 1 and Type 2 Mouse ModelsMolecular Neurobiology, 2018
- Fibroblast Growth Factor 14 Modulates the Neurogenesis of Granule Neurons in the Adult Dentate GyrusMolecular Neurobiology, 2015
- The role of S100B in the interaction between adipocytes and macrophagesObesity, 2013
- The blood–brain barrier in health and diseaseAnnals of Neurology, 2012
- Specific Role of Tight Junction Proteins Claudin-5, Occludin, and ZO-1 of the Blood–Brain Barrier in a Focal Cerebral Ischemic InsultJournal of Molecular Neuroscience, 2011
- Distribution of ICAM-1 immunoreactivity during aging in the human orbitofrontal cortexBrain, Behavior, and Immunity, 2007
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- P38 Mitogen Activated Protein Kinase Regulates Endothelial VCAM-1 Expression at the Post-transcriptional LevelBiochemical and Biophysical Research Communications, 1997
- Enhancement of blood-brain barrier permeability to sodium fluorescein by stimulation of opioid receptors in miceNaunyn-Schmiedeberg's Archives of Pharmacology, 1988